| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.16 | 0.006 |